Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trypsinogen is the inactive precursor (zymogen) of trypsin, a key digestive enzyme. It is synthesized and secreted primarily by the pancreas. It is activated by enteropeptidase in the small intestine to form trypsin, which then activates other digestive enzymes. Elevated levels of trypsinogen can be indicative of pancreatic injury or cystic fibrosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trypsinogen.